S

Synektik SA
WSE:SNT

Watchlist Manager
Synektik SA
WSE:SNT
Watchlist
Price: 276.4 PLN 1.25% Market Closed
Market Cap: 2.4B PLN

Synektik SA
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Synektik SA
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
S
Synektik SA
WSE:SNT
Research & Development
-zł3.3m
CAGR 3-Years
31%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Medapp SA
WSE:MDA
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Synektik SA
Glance View

Market Cap
2.4B PLN
Industry
Health Care

Synektik SA provides medical and information technology solutions. The company is headquartered in Warsaw, Woj. Mazowieckie and currently employs 145 full-time employees. The company went IPO on 2011-08-09. The company produces PACS software which allows running a diagnostic imaging laboratory. The company runs a research laboratory which performs acceptance and specialist tests of X-ray equipment. The firm sells medical equipment and operates a services center for imaging equipment. Synektik SA is a partner of Siemens. On November 28, 2013, the Company raised its stake in Miedzynarodowe Centra Medyczne Inwestycje Sp z o o to 100%.

SNT Intrinsic Value
HIDDEN
Show

See Also

What is Synektik SA's Research & Development?
Research & Development
-3.3m PLN

Based on the financial report for Sep 30, 2025, Synektik SA's Research & Development amounts to -3.3m PLN.

What is Synektik SA's Research & Development growth rate?
Research & Development CAGR 3Y
31%

Over the last year, the Research & Development growth was 86%. The average annual Research & Development growth rates for Synektik SA have been 31% over the past three years .

Back to Top